Evidence map›Paper›PMID 40226087›Full record

ArticleTranslational andrology and urology2025

Personalized prediction for recurrence of cystitis glandularis: insights from SHAP and machine learning models.

Yuyang Yuan, Fuchun Zheng, Jiming Yao, Kun Zhou, Jiaqing Yang, Xiaoqiang Liu, Hao Wan, Luyao Chen, Jieping Hu, Lizhi Zhou and 1 more

Abstract read
In one paragraph

Article in Translational andrology and urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yuyang Yuan *Department of Urology, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Fuchun Zheng *Department of Urology, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Jiming YaoDepartment of Urology, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Kun ZhouDepartment of Urology, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Jiaqing YangDepartment of Urology, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Xiaoqiang LiuDepartment of Urology, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Hao WanDepartment of Urology, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Luyao ChenDepartment of Urology, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Jieping HuDepartment of Urology, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Lizhi ZhouDepartment of Urology, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Bin FuDepartment of Urology, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cystitis glandularis (CG) is a rare urological condition characterized by glandular metaplasia of the bladder mucosa. Recurrence following transurethral resection (TUR) is a significant clinical challenge. Traditional predictive models often fail to capture the complexity of the data, resulting in insufficient accuracy. In contrast, machine learning (ML) has demonstrated substantial potential in medical prediction by identifying and analyzing complex patterns that are undetectable by conventional methods. This study aims to develop and evaluate an interpretable ML model to predict recurrence after TUR for CG, thereby improving clinical decision-making and patient outcomes. Methods: We analyzed predictors of recurrence using the least absolute shrinkage and selection operator (LASSO) and multivariate logistic regression. We developed and tested seven ML-based models: Cox proportional hazards model (CoxPH), LASSO regression, decision tree (rpart), random survival forest (RSF), gradient boosting machine (GBM), support vector machine (SVM), and extreme gradient boosting (XGBoost). Participants were diagnosed with CG by pathology following TUR and treated from 2012 to 2018. Model discrimination was assessed using the receiver operating characteristic (ROC) curve and area under the ROC curve (AUC), while model preference was evaluated through the Brier score (BS). Decision curve analysis (DCA) was used for model comparison. The SHapley Additive exPlanations (SHAP) method was employed for interpretation, providing insights into recurrence prediction and prevention strategies. Finally, user-friendly platform was developed, allowing users to predict CG recurrence by entering feature values into designated text boxes on the webpage. Results: The RSF model demonstrated the best performance in predicting recurrence, as indicated by superior ROC, DCA, and BS metrics. In SHAP, postoperative regular instillation (PRI) contributed the most to model construction. Conclusions: The RSF model effectively predicts CG recurrence, offering a framework for individualized treatment strategies. PRI was identified as the most significant risk factor influencing recurrence.

Indexed as

Cystitis glandularis (CG)machine learning (ML)online platformprediction modelSHapley Additive exPlanations (SHAP)

Identifiers

PMID40226087
PMCPMC11986474

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.